There are 2789 resources available
226P - Elderly breast cancer treated with standard curative intent treatment: An analysis of predictors of disease-free survival (DFS)
Presenter: Sai Kumar Soman
Session: ePoster Display
227P - Risk of breast cancer understaging through standard clinical and radiographic staging in Botswana
Presenter: Isaac Nkele
Session: ePoster Display
348P - Up-regulation of sorcin promotes glioblastoma progression via activating the PI3K/AKT/mTOR pathway
Presenter: Zhangya Pu
Session: ePoster Display
349P - The amount of cancer stem cells and the sensitivity to anticancer drugs in glioblastoma primary cell culture
Presenter: Olga Susova
Session: ePoster Display
232P - Longitudinal circulating tumor DNA (ctDNA) analysis in the phase 1b MONALEESASIA study of ribociclib (RIB) + endocrine therapy (ET) in Asian patients (pts) with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC)
Presenter: Yoon Sim Yap
Session: ePoster Display
234P - Effect of palbociclib (PAL) + endocrine therapy (ET) on time to chemotherapy (TTC) across subgroups of patients (pts) with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC): Post hoc analyses from PALOMA-2 (P2) and PALOMA-3 (P3)
Presenter: Hope Rugo
Session: ePoster Display
355P - Butterfly glioblastoma: Treatment strategies and clinical outcome
Presenter: Line Bjorland
Session: ePoster Display
Resources:
Abstract
236P - Real-world comparative effectiveness of palbociclib plus letrozole vs letrozole in older patients with metastatic breast cancer
Presenter: Hope Rugo
Session: ePoster Display
Resources:
Abstract
Slides
237P - Real-world outcomes of hormone receptor-positive (HR+) HER2-negative (HER2-) metastatic breast cancer (mBC) with high tumor mutational burden (hTMB) treated with immune checkpoint inhibitors (ICI)
Presenter: Saranya Chumsri
Session: ePoster Display